Earnings · China A-shares
Anhui Fengyuan Pharmaceutical Co., Ltd Class A (000153) earnings
Anhui Fengyuan Pharmaceutical Co., Ltd Class A published its Q3 report on 2026-10-28: net profit -14.51% year on year, +2.46% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -2.58% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -14.51%
- Excl. one-offs YoY
- +2.46%
- Net profit QoQ
- -57.86%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -2.77% | — |
| 3 days | -2.58% | — |
| 7 days | -1.48% | — |
| 14 days | -3.87% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 1 of 7 reports (average -1.27%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥85.73M | -14.51% | +2.46% | -22.45% | 0.18 | 3.98% | -2.58% | — | — |
| 2026 interim report | 2026-08-28 | ¥71.29M | -6.54% | +5.51% | -17.55% | 0.15 | 3.30% | -0.62% | -10.08% | -0.38% |
| 2026 Q1 report | 2026-04-29 | ¥37.01M | -2.67% | -7.06% | -11.14% | 0.08 | 1.74% | +1.72% | -13.46% | -14.40% |
| 2025 annual report | 2026-04-29 | ¥99.42M | -38.19% | -30.38% | -9.95% | 0.21 | 4.81% | +1.72% | -13.46% | -14.40% |
| 2025 Q3 report | 2025-10-24 | ¥100.28M | -31.92% | -36.39% | -4.18% | 0.22 | 4.85% | -1.62% | +1.18% | +1.40% |
| 2025 interim report | 2025-08-22 | ¥76.28M | -23.88% | -29.32% | -12.16% | 0.16 | 3.71% | -1.40% | -8.82% | -16.62% |
| 2025 Q1 report | 2025-04-25 | ¥38.02M | -19.12% | -19.55% | -16.05% | 0.08 | 1.86% | -3.54% | +6.06% | +2.81% |
| 2024 annual report | 2025-04-11 | ¥160.83M | +0.97% | -14.28% | +0.21% | 0.35 | 8.24% | -0.87% | +5.54% | +2.16% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.